Børsen
Confidence has increased in Bagsværd, where the weight-loss pill Wegovy is providing fertile ground for hopes of further upward adjustments. This remains the case even though the outlook for 2026 continues to indicate a dent in revenue for Novo Nordisk.
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.